Iain Dukes

Iain Dukes

Chairman at IOVANCE BIOTHERAPEUTICS, INC.

Net worth: 859 140 $ as of 2024-02-28

65 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Iain D. Dukes is a Chief Executive Officer at Viriom, Inc., a President & Director at Kartos Therapeutics, Inc., an Independent Director at Ikena Oncology, Inc., a Venture Partner at OrbiMed Advisors Private Equity, a Chairman at Iovance Biotherapeutics, Inc., an Executive Chairman at Theseus Pharmaceuticals, Inc., a President at Telios Pharmaceuticals, Inc. and a President & Chief Executive Officer at Arrys Therapeutics, Inc. He is on the Board of Directors at Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. and ReViral Ltd. Dr. Dukes was previously employed as a Member-Supervisory Board by Themis Bioscience GmbH, a SVP & Head-Business Development by Merck Research Laboratories Massachusetts LLC, a VP-External Research & Development by Amgen, Inc., a President & Chief Executive Officer by Essentialis, Inc., a VP-Scientific and Technology Licensing by GlaxoSmithKline, Inc., a Head-Exploratory Development by Glaxo Wellcome, Inc., a Principal by Glaxo, Inc., and a Senior VP-Business Development & Licensing by Merck & Co., Inc. He also served on the board at KaNDy Therapeutics Ltd. He received his undergraduate degree from the University of Bath, an undergraduate degree from the University of Oxford, a graduate degree from the University of Leeds and a doctorate degree from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-29 54,000 ( 0.02% ) 859 140 $ 2024-02-28
2023-09-07 0 ( -.--% ) - $ 2024-02-28

Iain Dukes active positions

CompaniesPositionStart
IOVANCE BIOTHERAPEUTICS, INC. Chairman 2016-08-03
IKENA ONCOLOGY, INC. Director/Board Member 2016-10-31
Director/Board Member -
Chief Executive Officer -
Director/Board Member 2020-01-31
Chief Executive Officer 2019-01-31
Director/Board Member 2017-09-07
Founder -
Founder 2017-08-31
░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Iain Dukes

Former positions of Iain Dukes

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Iain Dukes's experience

Training of Iain Dukes

University of Bath Undergraduate Degree
University of Oxford Doctorate Degree
University of Leeds Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Iain Dukes's experience

Connections

99

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
AMGEN INC.

Health Technology

MERCK & CO., INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

IKENA ONCOLOGY, INC.

Health Technology

Private companies21

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Glaxo Wellcome, Inc.

Health Technology

Glaxo, Inc.

Health Technology

Commercial Services

Distribution Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Iain Dukes